FDA
-
-
-
-
-
-
-
Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights
-
-
-
-
-
-
-
Novavax's COVID-flu combo vaccine shows strong immune response in trial
-
-
-
-
-
-
-
Novavax Appoints Charles Newton to Board of Directors
-
-
-
-
-
-
-
Drugmakers sink after key FDA official ousted as Trump plans health overhaul
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Novavax (NVAX)
-
-
-
-
-
-
-
U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
-
-
-
-
-
-
-
Novavax (NVAX) 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S.
-
322,868 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

